Outpatient managemen of adverse events related to cellular therapies

  • Malignant Hematology

    Outpatient managemen of adverse events related to cellular therapies

    Posted by Cara Williams on November 19, 2024 at 6:15 pm

    Hi everyone,

    Our community practice wants to start administering bispecifics to our multiple myeloma patients.

    Have other community practices started doing this?

    Could you share information about the APP staffing you put in place to support these patients?

    Cara Williams replied 2 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .